Immunogenicity and safety of live attenuated varicella vaccine in 12 and 18 month-old children, with and without concomitant administration of measles-mumps-rubella [MMR] vaccine
Phase of Trial: Phase I/II
Latest Information Update: 27 Apr 2010
At a glance
- Drugs Varicella zoster virus vaccine live (Primary) ; Measles mumps and rubella virus vaccine; MMR-varicella zoster virus vaccine
- Indications Chickenpox; Measles; Mumps; Rubella
- Focus Pharmacodynamics
- 27 Apr 2010 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
- 26 Jul 2007 Status changed from recruiting to discontinued.
- 16 Dec 2005 New trial record.